You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

T-Lymphocytes (EBV-CTLs)

Showing 1 - 25 of 8,905
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Lymphocytic Leukemia, Lymphoma Trial in New York (Biological/Genetically Modified T cells, Cyclophosphamide-based chemo)

Active, not recruiting
  • Acute Lymphocytic Leukemia
  • Lymphoma
  • Biological/Genetically Modified T cells
  • Cyclophosphamide-based chemotherapy
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 3, 2023

Epstein-Barr Virus Infections, Primary Immune Deficiency Disorder Trial in United States (cytotoxic t-lymphocytes)

Recruiting
  • Epstein-Barr Virus Infections
  • Primary Immune Deficiency Disorder
  • cytotoxic t-lymphocytes
  • Los Angeles, California
  • +7 more
Sep 27, 2022

Hodgkin Disease, Non-Hodgkin Lymphoma, Severe Chronic Active Epstein Barr Virus Trial in Houston (MABEL CTLs, Cyclophosphamide,

Recruiting
  • Hodgkin Disease
  • +5 more
  • MABEL CTLs
  • +2 more
  • Houston, Texas
  • +1 more
Jan 13, 2023

Hodgkin's Disease, Non-Hodgkin's Lymphoma, Lymphoproliferative Disease Trial in Houston (EBV-specific T cells: A, EBV-specific T

Recruiting
  • Hodgkin's Disease
  • +3 more
  • EBV-specific T cells: A
  • EBV-specific T cells: B
  • Houston, Texas
  • +1 more
Jun 28, 2022

Lymphoma, Hodgkin's Disease, Relapse Trial in Houston (TGFbeta resistant LMP-specific CTLs)

Active, not recruiting
  • Lymphoma
  • +3 more
  • TGFbeta resistant LMP-specific CTLs
  • Houston, Texas
  • +1 more
Dec 8, 2021

Neuroblastoma Trial in Houston (EBV specific CTLs)

Active, not recruiting
  • Neuroblastoma
  • EBV specific CTLs
  • Houston, Texas
    Texas Children's Hospital
Feb 2, 2022

EBV Lymphoma, Post-transplant Lymphoproliferative Disease (PTLD) Trial in Switzerland (Donor-derived ex-vivo expanded EBV Tscm

Not yet recruiting
  • EBV Lymphoma
  • Post-transplant Lymphoproliferative Disease (PTLD)
  • Donor-derived ex-vivo expanded EBV Tscm CTL
  • Basel, Switzerland
  • +7 more
Jan 25, 2023

Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Houston (autologous or syngeneic PBTLs and EBV-CTLs)

Active, not recruiting
  • Non-Hodgkin Lymphoma
  • Chronic Lymphocytic Leukemia
  • autologous or syngeneic PBTLs and EBV-CTLs
  • Houston, Texas
  • +1 more
Feb 6, 2022

Multiple Myeloma Trial in Houston (TAA-specific CTLs, TAA-specific CTLs- fixed dose)

Recruiting
  • Multiple Myeloma
  • TAA-specific CTLs
  • TAA-specific CTLs- fixed dose
  • Houston, Texas
    Houston Methodist Hospital
Nov 11, 2022

EBV-induced Lymphomas, EBV-associated Malignancies, Transplant Patients With EBV Viremia at High Risk of Developing a Recurrent

Completed
  • EBV-induced Lymphomas
  • +2 more
  • allogeneic Epstein-Barr virus-specific cytotoxic T lymphocytes (EBV-CTLs)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 21, 2020

Hodgkins Lymphoma, Non Hodgkins Lymphoma Trial in Houston (TAA-specific CTLs)

Recruiting
  • Hodgkins Lymphoma
  • Non Hodgkins Lymphoma
  • TAA-specific CTLs
  • Houston, Texas
    Texas Children's Hospital
Jul 14, 2022

Cytomegalovirus Infections, Primary Immune Deficiency Disorder Trial in United States (viral specific cytotoxic t-lymphocytes)

Recruiting
  • Cytomegalovirus Infections
  • Primary Immune Deficiency Disorder
  • viral specific cytotoxic t-lymphocytes
  • Los Angeles, California
  • +7 more
Sep 27, 2022

Congenital Cytomegaloviral (CMV) Disease Trial in United States (CMV Cytotoxic T-Lymphocytes, Anti-viral Therapy)

Recruiting
  • Congenital Cytomegaloviral (CMV) Disease
  • CMV Cytotoxic T-Lymphocytes
  • Anti-viral Therapy
  • Saint Louis, Missouri
  • +3 more
Oct 24, 2022

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +2 more
  • SARS-CoV-2 Antigen-specific Cytotoxic T-lymphocytes
  • Houston, Texas
    M D Anderson Cancer Center
Jul 13, 2022

Adenovirus, Primary Immune Deficiency Disorder Trial in United States (cytotoxic t-lymphocytes)

Recruiting
  • Adenovirus
  • Primary Immune Deficiency Disorder
  • cytotoxic t-lymphocytes
  • Los Angeles, California
  • +8 more
Sep 27, 2022

Hodgkin Disease, Non Hodgkin Lymphoma, Lymphoepithelioma Trial in Houston (LMP1/2 CTLs (ALCI - Group A), LMP1/2 CTLs (ALCI -

Completed
Has Results
  • Hodgkin Disease
  • +3 more
  • LMP1/2 CTLs (ALCI - Group A)
  • +8 more
  • Houston, Texas
  • +1 more
May 26, 2020

Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in Australia, Canada, United States

Active, not recruiting
  • Primary Progressive Multiple Sclerosis
  • Secondary Progressive Multiple Sclerosis
  • ATA188
  • Placebo
  • La Jolla, California
  • +33 more
Jul 21, 2022

Rhabdomyosarcoma Trial in Houston (TAA-Specific CTLs)

Completed
  • Rhabdomyosarcoma
  • TAA-Specific CTLs
  • Houston, Texas
  • +1 more
Apr 8, 2022

Opportunistic Fungal Infection, Opportunistic Viral Infection, Bone Marrow Transplant Infection Trial in Patra, Thessaloníki

Recruiting
  • Opportunistic Fungal Infection
  • +2 more
  • Pentavalent-specific T cells (penta-STs)
  • Patra, Greece
  • +1 more
Jul 26, 2022

EBV-Related Hodgkin Lymphoma, Lymphoproliferative Disorders, EBV Related Non-Hodgkin's Lymphoma Trial in Houston (Dose Level 1A:

Not yet recruiting
  • EBV-Related Hodgkin Lymphoma
  • +2 more
  • Dose Level 1A: 2 x 10^7 cells/m2
  • +4 more
  • Houston, Texas
  • +1 more
Feb 7, 2022

Adenovirus Infection, BK Virus Infection, Cytomegaloviral Infection Trial in Houston (Virus-specific Cytotoxic T-lymphocytes)

Recruiting
  • Adenovirus Infection
  • +6 more
  • Virus-specific Cytotoxic T-lymphocytes
  • Houston, Texas
    M D Anderson Cancer Center
Jan 6, 2023

Breast Cancer Trial in Houston (TAA-specific CTLs)

Active, not recruiting
Has Results
  • Breast Cancer
  • TAA-specific CTLs
  • Houston, Texas
  • +1 more
May 20, 2022

Serologically Active Adult Systemic Lupus Erythematosus Trial in Nantes, Paris (Autologous EBV specific CTL infusion)

Terminated
  • Serologically Active Adult Systemic Lupus Erythematosus
  • Autologous EBV specific CTL infusion
  • Nantes, France
  • +2 more
Mar 24, 2022

Viral Infections After HSCT Trial in Washington (VSTs)

Active, not recruiting
  • Viral Infections After HSCT
  • VSTs
  • Washington, District of Columbia
    Childrens National Medical Center
Aug 30, 2022

Covid19 Trial in United States (Standard of Care, SARS-CoV2-CTLS)

Recruiting
  • Covid19
  • Standard of Care
  • SARS-CoV2-CTLS
  • Valhalla, New York
  • +3 more
Jan 10, 2022